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Summary
Introduction:  Medium-term  results  for  total  ankle  replacement  (TAR)  are  in  general  satisfactory,
but there  is  a  high  redo  rate  for  periprosthetic  osteolysis  associated  with  the  AES  implant.
Hypothesis:  Comparing  radioclinical  ﬁndings  and  histologic  analysis  of  implant  revision  proce-
dure specimens  can  account  for  the  elevated  rate  of  osteolysis  associated  with  the  AES  TAR
implant.
Material and  method:  In  a  prospective  series  of  84  AES  TAR  implants  (2003—2008),  25  underwent
revision for  osteolysis  (including  three  undergoing  revision  twice)  at  a  mean  59.8  months.  Eight
patients had  hydroxyapatite  (HA)  coated  models  and  the  others  had  titanium-hydroxyapatite
(Ti-HA)  coatings.  Radiographs  were  systematically  analyzed  on  Besse’s  protocol  and  evolution
was monitored  on  AOFAS  scores.  The  94  specimens  taken  for  histologic  analysis  during  revision
were re-examined,  focusing  speciﬁcally  on  foreign  bodies.
Results:  Macroscopically,  no  metallosis  or  polyethylene  wear  was  found  at  revision.  AOFAS
global and  pain  scores  fell  respectively  from  89.7/100  at  1  year  postoperatively  to  72.9  before
revision and  from  32.5/40  to  20.6/40,  although  global  scores  were  unchanged  in  25%  of  patients.
Radiologically,  all  patients  showed  tibial  and  talar  osteolytic  lesions,  45%  showed  cortical  lysis
and in  25%  the  implant  had  collapsed  into  the  cysts.  All  specimens  showed  macrophagic  gran-
ulomatous  inﬂammatory  reactions  in  contact  with  a  foreign  body;  the  cysts  showed  necrotic
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remodeling.  Some  of  the  foreign  bodies  could  be  identiﬁed  on  optical  histologic  examination
with polyethylene  in  95%  of  the  specimens  and  metal  in  60%  (100%  of  HA-coated  models  and
33.3% of  Ti-HA-coated  models).  Unidentiﬁable  material  was  associated:  a  brownish  pigment  in
Ti-HA-coated  models  (33.3%)  and  ﬂakey  bodies  in  44.4%  of  the  HA-coated  models  and  18.2%  of
the Ti-HA-coated  models.
Discussion:  The  phenomenon  of  periprosthetic  osteolysis  is  still  poorly  understood,  although
implant wear  debris  seems  to  be  implicated.  All  the  patients  with  HA-coated  implants  with
modular tibial  stem  had  metal  particles  in  the  tissue  around  the  implant,  although  their  exact
nature could  not  be  determined.  The  double-layer  Ti-HA  coating  may  induce  delamination  by
fretting while  the  biological  bone  anchorage  is  forming.
Level of  evidence:  Prospective  cohort  study  —  Level  IV.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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otal  ankle  replacement  (TAR)  is  currently  an  acceptable
reatment  for  degenerative  ankle  lesions  of  whatever  cause
1—3].  Ten-year  implant  survivorship,  however,  was  only  62%
o  72%  in  the  Scandinavian  registries  [4—7],  compared  to  80%
o  90%  as  in  series  mainly  reported  by  the  designers  [8,9],
nd  90%  to  98%  for  hip  and  knee  replacements  [10].
Periprosthetic  radiolucency  and  osteolysis  has  been  lit-
le  or  poorly  analyzed  in  TAR  series.  Massive  ‘‘ballooning’’
eriprosthetic  osteolysis  was  reported  mainly  in  connection
ith  the  Agility  implant  (a  2-component  model  much  used  in
he  USA),  with  a  rate  of  15%  and  8.5%  implant  subsidence  in
netch’s  series  [11]  of  132  implants  at  9  years’  mean  follow-
p.
In  2009,  our  team  reported  a  prospective  series
2003—2006)  of  50  Ankle  Evolutive  System  (AES)  TARs  [12],
howing  29%  and  22%  rates  of  severe  (>1  cm)  tibial  and  talar
ysts  respectively,  at  45  months  follow-up.  This  cystic  oste-
lysis  induced  mechanical  complications  due  to  tibial  and
alar  cortical  microfracture,  notably  involving  collapse  of
he  talar  component,  requiring  reconstruction  arthrodesis.
The  cause  of  these  cysts  remains  unclear.  The  hypothesis
f  the  present  study  was  that  comparison  between  histology
nd  radioclinical  analysis  can  account  for  the  onset  of  severe
eriprosthetic  osteolysis  with  the  AES  TAR.
aterial and methods
atients
 continuous  series  of  80  patients  with  84  AES  implants
nderwent  TAR  between  November  2003  and  May  2008;
urgery  was  performed  by  a  single  senior  surgeon  (JLB),  in
 single  center,  following  a  single  protocol  of  surgery  and
ostoperative  rehabilitation.
Twenty  of  these  patients  (13  male,  7  female:  22  ankles)
equired  surgical  revision  for  periprosthetic  osteolysis  with
hreatening  evolution  or  directly  associated  with  mechanical
omplications.There  were  25  revision  procedures:  in  eight  cases,  the
mplant  was  removed  and  arthrodesis  was  performed;  14
ases  were  treated  by  curettage  and  grafting  of  the  cyst
ith  replacement  of  the  polyethylene  bearing,  and  three  of (hese  patients,  treated  conservatively,  required  reinterven-
ion  by  arthrodesis  due  to  severe  cystic  recurrence  (Fig.  1).
n  three  cases,  revision  was  performed  in  a  different  cen-
er,  and  the  histology  specimens  could  not  be  included  in
he  present  analysis:  one  patient  underwent  primary  revi-
ion  arthrodesis,  and  one  was  treated  ﬁrst  by  curettage  and
rafting,  with  arthrodesis  4  years  later.  The  present  analy-
is  was  thus  founded  on  22  histology  specimens  taken  during
evision  of  AES  TARs.  Two  other  patients  from  the  series  were
cheduled  for  arthrodesis  at  the  time  of  writing.
The  initial  TAR  indication  was  post-traumatic  osteoarthri-
is  in  11  cases  and  osteoarthritis  secondary  to  chronic
igament  instability  in  the  other  11  cases.  Mean  age  at  TAR
as  50.5  years  (range,  21—74  years).
mplant  characteristics
he  implants  in  question  were  AES  (Ankle  Evolutive  System)
ARs  [13], manufactured  by  Transystem  (Nîmes,  France)
nd  marketed  by  Biomet  (Valence,  France).  The  design  was
eveloped  from  the  Buechel  Pappas  TAR,  with  three  non-
tressed  non-cemented  components.  The  tibial  and  talar
omponents  were  in  chromium—cobalt  alloy  (Co—Cr)  with
he  mobile  bearing  in  ultra-high  molecular  weight  polyeth-
lene  (UHMWPE).  Two  versions  were  successively  marketed:
he  ﬁrst  had  a  modular  tibial  component,  with  a  Morse  taper
o  adapt  the  tibial  stem,  and  a  hydroxyapatite  (HA)  coating;
s  of  August  2004,  this  was  replaced  by  a  second  generation
ES  TAR  with  a  monoblock  tibial  stem  and  a  coating  com-
rising  a  thick  layer  of  plasma-pulverized  titanium  covered
y  hydroxyapatite  (Ti-HA).
adiology
rospective  radiologic  monitoring  was  systematic:
 plain  AP  and  lateral  weight-bearing  ankle  views,  pre-
operatively,  postoperatively,  at  6  months  and  then
annually;
 3D  ankle  CT  scan,  pre-operatively  and  at  3  and  5  years.X-rays  were  analyzed  on  the  protocol  of  Besse  et  al.  [12]
Fig.  2).
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Figure  1  Patient  distribution  according  to  type  of  revision  and  of  graft.
Figure  2  Plain  X-ray  periprosthetic  osteolysis  assessment  protocol  for  AES  TAR,  following  Besse.  A.  AP  ankle  view:  Region  1:  lateral
tibia, Region  2:  medial  tibia,  Region  3:  lateral  malleolus,  Region  4:  medial  malleolus,  Region  5:  under  talar  component.  B.  Lateral
ankle view:  Region  6:  posterior  tibia,  Region  7:  anterior  tibia,  Region  8:  posterior  talus  under  implant,  Region  9:  anterior  talus  under
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simplant, Region  10:  talar  neck  and  head.  Lesion  classiﬁcation  by
grade A  =  2—5  mm,  Cyst  grade  B  =  5—10  mm,  Cyst  grade  C  =  10—2
CT  scan  was  systematic  before  revision,  to  map  lesions
precisely  and  look  for  any  cortical  lysis.
Inclusion  criteria  and  patient  data
The  indications  for  revision  were:
•  radiologically  evolutive  periprosthetic  cysts  of  more  than
3  cm  diameter  with  risk  of  talar  and/or  tibial  component
collapse  into  the  cysts;
•  mechanical  complications  related  to  periprosthetic  oste-
olysis:  implant  collapse  into  cyst  or  cortical  lysis  with
painful  microfracture.
s
o
w (mm)  for  all  10  regions:  N  =  normal  0,  L  =  lucency  0—2  mm,  Cyst
,  Cyst  grade  D  =  20—30  mm,  Cyst  grade  E  =  >30  mm.
None  of  the  patients  had  history  of  ankle  sepsis  or  signs  of
hronic  or  acute  sepsis.  The  functional  impact  of  the  oste-
lysis  was  assessed  using  the  AOFAS  functional  score  [14]
head  of  TAR,  at  1  year  postoperatively  and  ahead  of  revi-
ion.
istology
he  surgical  specimens  were  ﬁxed  immediately  in  buffered
ormaldehyde  solution.  After  inclusion  in  parafﬁn,  3—5  
lices  were  prepared  for  slides  with  hematoxylin—eosin
taining.  All  the  samples  were  analyzed  by  senior  pathol-
gists  of  our  center,  who  sent  back  written  reports.
Between  March  and  December  2012,  all  these  samples
ere  re-examined  by  a  senior  pathologist  (RB)  and  a  junior
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urgeon  (FD)  under  optical  microscopy  in  standard  and  polar-
zed  light.  A  form  was  ﬁlled  out  for  each  slide,  quantifying
nd  describing  the  inﬂammatory  reaction  and  necrosis,  ana-
yzing  the  synovial  sheath  and  bone  tissue,  and  noting  any
oreign  bodies.
esults
he  mean  interval  between  TAR  and  revision  was
9.8  months  (range,  26—108  months).  No  macroscopic  met-
llosis  was  found  during  revision.  None  of  the  polyethylene
earings  showed  macroscopic  signs  of  wear.
unctional  results
ean  AOFAS  functional  score  was  37.3  (23—54)  pre-TAR  and
9.7  (78—100)  at  1  year;  by  revision,  this  had  fallen  to  72.9
40—100).  This  fall  was  mainly  due  to  pain,  with  a  mean  pain
core  of  32.5/40  at  1-year  post-TAR  and  20.6  at  revision.
adiology  results
volutive  osteolysis  was  found  at  the  1-year  check-up  for
wo  patients,  but  for  most  was  diagnosed  on  the  second
ear  radiographs.  All  patients  had  bipolar  lesions  (Table  1
nd  Fig.  3).  On  pre-revision  CT,  eight  ankles  showed  tibial
r  talar  cortical  lysis.  Six  patients  showed  implant  failure,
mplicating  osteolysis:  one  medial  malleolar  fracture,  and
ve  cases  of  talar  component  collapse.
istology  results total  of  94  specimens  were  analyzed.  For  each  ankle,  there
ere  between  three  and  eight  specimens  including  at  least
ne  slide  of  synovial  tissue,  one  of  periprosthetic  bone  tissue
nd  one  of  cyst  contents  (Tables  2  and  3).
t
p
p
igure  3  Distribution  of  grade  C,  D  and  E  osteolytic  lesions,  in
eriprosthetic  osteolysis  assessment  protocol  for  revision  of  AES  TARF.  Dalat  et  al.
The  synovial  sheath  systematically  showed  abrasion  and
as  often  covered  in  ﬁbrinoid  necrosis  (Fig.  4).  There
ere  no  polynuclear  inﬁltrates.  Bone  tissue  showed  signs  of
esorption  with  macrophagic  granulomatous  reaction  in  the
edullary  tissue,  comprising  histiocytes  and  polynucleate
iant  cells.
The  ‘‘heart’’  of  the  cysts  comprised  acellular  eosinophilic
ecrosis,  free  of  foreign  bodies.  At  the  periphery  of  this
ecrotic  region,  there  was  a  macrophagic  inﬂammatory
eaction  of  the  same  type  as  found  in  the  bone  tissue,  but
ith  a  predominance  of  histiocytes;  intensity  was  moderate
n  73.3%  of  the  samples  and  high  in  15.7%.
Various  materials  were  found  within  the  inﬂammatory
ranulomas.  Some  bodies  were  clearly  foreign:  polyethyl-
ne  or  metal  debris  as  classically  described  in  resorption  in
ontact  with  the  implant.  The  polyethylene  was  in  the  form
f  colorless  translucent  fragments,  strongly  birefringent
nder  polarized  light;  they  were  either  large  (20—25  m)
nd  extracellular,  in  contact  with  polynucleate  giant  cells,
r  smaller  (2—5  m),  in  the  form  of  debris  in  the  histio-
yte  cytoplasm,  difﬁcult  to  see  under  standard  light  but
asily  picked  out  under  polarized  light  (Fig.  5).  They  were
ound  in  68  samples  (19/20  ankles:  95%):  in  12  of  the  13
ases  of  curettage-grafting  and  all  seven  cases  of  arthrode-
is.
There  were  also  metal  particles  (0.3—1.5  m)  within  the
ytoplasm  of  spumous  histiocytes,  found  in  50  samples  (12
nkles:  60%)  (Fig.  6).  Amounts  were  small,  except  in  cases
 and  19,  but  were  found  in  all  patients  with  HA-coated
mplants  and  in  four  (33.3%)  of  those  with  Ti-HA  coatings.
icroscopy  was  unable  to  determine  whether  the  particles
ere  of  chromium,  cobalt  or  titanium.  It  is  noteworthy  that
he  HA-coated  models  had  modular  tibial  stems,  adapted  to
he  bearing  by  a  Morse  taper,  which  was  found  on  revision
o  have  come  loose.
We  also  found  a  brownish  pigment  in  the  histiocyte  cyto-
lasm  (Fig.  7).  The  aspect  did  not  suggest  a  formaldehyde
igment;  it  was  negative  on  Perls’  staining,  and  therefore
 percentage,  for  each  region,  according  to  the  plain  X-ray
.
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Table  1  Radiologic  analysis  and  osteolysis  complications  in  the  series  of  20  patients.
Side  Time  to  ﬁrst  cysts,
and  location
Pre-revision  radiographic
analysis  (Besse  protocol)
Implantation-revision
interval  (months)
Mechanical
complications
Case  1  Left  2  years,  tibia  Cysts  C:  regions  1,  6,
7/Cysts  D:  region  5/Cysts
E: regions  2,  8,  9
107  Talar  collapse
Case 2  Right  4  years,  tibia  and
talus
Cysts  B:  regions  1,  6/Cysts
C: regions  5,  7/Cysts
D: region  9
108  Talar  collapse
Case 3  Right  3  years,  talus  Cysts  D:  regions  5,  9,
10/Lucency:  regions  1,  2
57  Talar  collapse
Case 4 Left  2  years,  tibia Cysts  C:  regions  5,  7,  8,  9,
10/Lucency:  regions  1,  2
82  Cortical  lysis
Case 5  Left  4  years,  tibia  and
talus
Cysts  C:  regions  1,  2,  6,
7/Cysts  D:  regions  5,  8,  9
104  Cortical  lysis
Case 6  Right  2  years,  talus  Cysts  C:  regions  5,  7/Cysts
D: regions  8,  9
92  0
Case 7  Left  2  years,  tibia  Cysts  C:  regions  1,  2,  5,  6,
7/Cysts  B:  regions  8,  9
60  0
Case 8  Right  4  years,  tibia  Cysts  C:  regions  2,  5,
9/Cysts  D:  regions  1,  6
83  Cortical  lysis
Case 9  Left  2  years,  tibia  Cysts  B:  regions  2,  5,
6/Cysts  C:  regions  1,  4,  7,
8, 9
42  0
Case 10 Left  2  years,  tibia  and
talus
Cysts  C:  regions  2,  5,  7,  9,
10/Cysts  D:  regions  1,  6
50  Cortical  lysis
Case 11 Left  2  years,  tibia  and
talus
Cysts  B:  regions  6,  7,
8/Cysts  C:  regions  1,  2,
9/Cyst  D:  region  5
56  Cortical  lysis
Case 12  Left  3  years,  tibia  Cysts  C:  regions  5,  6,
9/Cysts  D:  regions  1,  7
48  Cortical  lysis
Case 13  Right  2  years,  tibia  and
talus
Cysts  C:  regions  5,  6,
9/Cysts  D:  regions  1,  2,  7,
8
49  Cortical  lysis
Case 14  Left  2  years,  tibia  and
talus
Cysts  C:  regions  1,  5,  6,  7,
8, 9/Cyst  B:  region  2
39  0
Case 15  Left  2  years,  tibia  Cysts  A:  regions  5,  8,
9/Cysts  B:  region  4
30  MM  fracture
Case 16  Right  1  year,  tibia  Cysts  C:  regions  1,  5,  6,
9/Cyst  D:  region  2
45  Cortical  lysis
Case 17  Left  1  year  tibia  Cysts  C:  regions  1,  5,
8/Cysts  D:  regions  7,  9
51  0
Case 18  Right  2  years,  tibia  and
talus
Cysts  C:  regions  1/Cysts  D:
regions  2,  5,  6,  7,  8,  9
73  Talar  collapse
Case 19  Left  2  years,  tibia  and
talus
Cysts  C:  regions  1,  2,  5,  6,
7/Cysts  D:  regions  8,  9
57  Talar  collapse
Case 20  Left  2  years,  talus  Cysts  A:  regions  2,  7/Cysts
 10
26  0
c
f
oC: regions  5,  9,
MM: medial malleolus fracture.
not  a  hemosiderin  pigment.  It  was  found  in  nine  sam-
ples  (four  ankles)  from  patients  with  HA-Ti-coated  implants
(33.3%  of  HA-Ti-coated  implants).  There  were  also  15—25  m
particles  in  the  cytoplasm  of  giant  cells;  they  had  a  pale,
ﬂakey  aspect,  non-refringent  under  polarized  light  (Fig.  8).
They  were  found  in  12  samples  (six  ankles:  30%):  44.4%  of
HA-coated  implants  and  18.2%  of  HA-Ti-coated  implants;
these  samples  also  showed  metal  and  polyethylene  parti-
cles.
s
d
p
sIn  the  two  ankles  (cases  5  and  8)  that  underwent
urettage-grafting  followed  by  arthrodesis,  there  was  no  dif-
erence  on  histology  between  the  specimens  from  the  two
perations.
A  preliminary  study  by  X-ray  diffraction  and  infrared
pectrometry  of  two  samples  of  cyst  contents  failed  to
etermine  the  nature  of  the  foreign  bodies  found  in  the
eriprosthetic  tissue,  as  quantities  were  too  small  for  the
ensitivity  of  the  techniques  used.
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Table  2  Anatomopathology  results  for  the  13  cases  with  curettage-grafting  conserving  implant.
Implant  no
in  series
Date  of
implantation
(dd/mm/yyyy)
Type  of
coating
Implantation  to
revision  interval
(months)
Number  of
slides
Joint  tissue  Talar  tissue  Tibial  tissue
Case  4  TAR  No10  01/12/2003  HA  82  3  Polyethylene:  +
Metal:  +
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Case 5  TAR  No13  05/01/2004  HA  61  8  Polyethylene:  +++
Metal:  ++
Other  material:  +
Polyethylene:  ++
Metal:  +++
Other  material:  +
Polyethylene:  ++
Metal:  +++
Other  material:  +
Case 6  TAR  No14  02/02/2004  HA  92  6  Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Case 7  TAR  No16  16/03/2004  HA  60  3  Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  +
Metal:  +
Other  material:  0
Case 8  TAR  No18  03/05/2004  HA  54  6  Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  +
Metal:  +
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Case 9  TAR  No25  25/11/2004  Ti-HA  42  3  Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Case 10  TAR  No29  07/02/2005  Ti-HA  50  7  Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  +
Metal:  +
Other  material:  +
Case 11  TAR  No30  15/02/2005  Ti-HA  56  4  Polyethylene:  ++
Metal:  +
Other  material:  0
Polyethylene:  0
Metal:  +
Other  material:  0
Polyethylene:  ++
Metal:  +
Other  material:  0
Case 12  TAR  No32  17/03/2005  Ti-HA  48  4  Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Case 13  TAR  No35  18/08/2005  Ti-HA  49  3  Polyethylene:  +
Metal:  0
Other  material:  +
Polyethylene:  0
Metal:  0
Other  material:  +
Polyethylene:  0
Metal:  0
Other  material:  +
Case 14  TAR  No37  13/10/2005  Ti-HA  39  3  Polyethylene:  ++
Metal:  0
Other  material:  +
Polyethylene:  ++
Metal:  0
Other  material:  0
Polyethylene:  ++
Metal:  0
Other  material:  +
Case 16  TAR  No40  05/01/2006  Ti-HA  45  4  Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  0
Polyethylene:  0
Metal:  0
Other  material:  +
Case 17  TAR  No42  30/01/2006  Ti-HA  51  3  Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
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Table  3  Anatomopathology  results  for  the  9  cases  with  ankle  arthrodesis.
Implant  no
in  series
Date  of
implantation
(dd/mm/yyyy)
Type  of
coating
Implantation  to
revision  interval
(months)
Number  of
slides
Joint  tissue Talar  tissue Tibial  tissue
Case  1 TAR  No3  Bis 10/07/2003  HA  107  8  Polyethylene:  +++
Metal:  ++
Other  material:  0
Polyethylene:  ++
Metal:  +
Other  material:  0
Polyethylene:  ++
Metal:  0
Other  material:  0
Case 2 TAR  No4 02/09/2003  HA  108  4  Polyethylene:  ++
Metal:  ++
Other  material:  0
Polyethylene:  ++
Metal:  +
Other  material:  0
Polyethylene:  ++
Metal:  +
Other  material:  0
Case 3 TAR  No9 17/11/2003  HA  57  3  Polyethylene:  ++
Metal:  +
Other  material:  +
Polyethylene:  ++
Metal:  +
Other  material:  0
Polyethylene:  ++
Metal:  +
Other  material:  0
Case 5  TAR  No13  05/01/2004  HA  104  6  Polyethylene:  +++
Metal:  ++
Other  material:  +
Polyethylene:  ++
Metal:  +++
Other  material:  +
Polyethylene:  ++
Metal:  +++
Other  material:  +
Case 8  TAR  No18  03/05/2004  HA  83  8  Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  +
Metal:  +
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Case 15  TAR  No39  21/11/2005  Ti-HA  30  3  Polyethylene:  +
Metal:  0
Other  material:  +
Polyethylene:  +
Metal:  0
Other  material:  +
Polyethylene:  +
Metal:  0
Other  material:  0
Case 18  TAR  No53  26/10/2006  Ti-HA  73  4  Polyethylene:  +
Metal:  +
Other  material:  +
Polyethylene:  +
Metal:  ++
Other  material:  0
Polyethylene:  +
Metal:  +
Other  material:  0
Case 19  TAR  No63  17/04/2007  Ti-HA  57  8  Polyethylene:  +
Metal:  +
Other  material:  0
Polyethylene:  +
Metal:  ++
Other  material:  0
Polyethylene:  +
Metal:  0
Other  material:  0
Case 20 TAR  No84 17/04/2008  Ti-HA  26  3  Polyethylene:  ++
Metal:  0
Other  material:  0
Polyethylene:  ++
Metal:  0
Other  material:  0
Polyethylene:  ++
Metal:  0
Other  material:  0
S292  F.  Dalat  et  al.
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Figure  5  Histiocytic  inﬂammatory  inﬁltrate  with  a  few  giant
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Several  reports  of  short-  and  medium-term  ﬁndings  with
the  AES  ankle  prosthesis  focused  on  periprosthetic  osteoly-
sis  and  imaging  of  the  bone/implant  interface  [12,24—27].
Koivu  et  al.  [24]  reported  a  21%  severe  lesion  rate  atigure  4  Necrotic  material  covering  the  synovium,  with
pithelial  abrasion.
iscussion
ur  experience  with  AES  TAR  ﬁnds  a  28.6%  rate  of  revision  for
evere  evolutive  periprosthetic  osteolysis.  Histologic  analy-
is  of  revision  specimens  found  two  clearly  identiﬁable  types
f  foreign  bodies  related  to  implant  wear:  polyethylene,  in
5%  of  the  cases,  but  also  metal  particles  in  60%.  Two  other
ypes  of  material  were  associated,  the  nature  and  indeed
he  actual  foreignness  of  which  could  not  be  determined:
 brownish  pigment,  in  20%  of  the  cases  that  was  neither
uggestive  of  the  formaldehyde  involved  in  the  histology  ﬁx-
tion  liquid  and  technique  nor  a  hemosiderin  pigment,  being
egative  for  Perls’  staining;  and,  in  30%  of  the  cases,  ﬂakey
ytoplasm  inclusions  found  in  macrophages.
The  strong  points  of  the  present  study  lie  in  its  continuous
rospective  design,  involving  a  single  senior  surgeon.  Histol-
gy  specimens  were  re-analyzed  by  an  independent  senior
athologist.  The  weak  point  lies  in  the  fact  that  the  surface
oating  was  changed  in  2004,  which  may  induce  bias  in  the
nalysis  of  the  pathology  results  and  a  limitation  on  the  abil-
ty  of  a  simple  histologic  examination  to  identify  the  exact
ature  of  the  material  found.
The  exact  physiopathology  of  osteolysis  is  unclear.  In  hip
rthroplasty,  osteolysis  is  seen  as  a  foreign-body  reaction  to
ement  and  polyethylene  wear  debris  [15,16].  Particles  of
olyethylene  (UHMWPE),  PMMA  cement,  chromium—cobalt
Cr—Co),  titanium  alloys,  alumina  (Al2O3)  and  zirconium
ioxide  (ZrO2)  are  all  implicated  [17].  This  biological  activ-
ty,  however,  depends  more  on  the  size  than  the  nature  of
he  particles  [18].  Particles  of  polyethylene,  of  any  kind  of
etal  (stainless  steel,  Co—Cr,  titanium)  or  ceramic  mea-
uring  less  than  7  m  may  be  phagocyted  by  macrophages,
eleasing  pro-inﬂammatory  cytokines  [19—21];  this  triggers cascade  of  biological  reactions,  including  the  release  of
he  receptor  activator  of  NF-kappaB  (RANK)  which  binds
o  the  receptor  activator  of  NF-kappaB  ligand  (RANKL),
F
hells (×40  lens).  A.  standard  light;  B.  polarized  light,  revealing
olyethylene  particles  in  contact  with  a  polynucleate  giant  cell.
nducing  osteoclastogenesis  and  osteolysis  and  inhibiting
steogenesis  [15,16,18,22,23].igure  6  Inﬂammatory  inﬁltrate  with  metal  particles  within
istiocyte  cytoplasm  (×100  lens).
Histologic  study  of  periprosthetic  osteolytic  lesions  after  AES  tot
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tFigure  7  Brownish  pigment  around  histiocyte  nuclei  (×40
lens).
31  months,  Harris  et  al.  [25]  a  24%  rate  of  signiﬁcant  lesions
at  58  months,  Leemrijse  et  al.  [26]  a  77%  rate  of  cysts  on
radiographs  and  100%  on  CT  scans  at  39  months,  and  Kokko-
nen  et  al.  [27]  a  79%  rate  of  osteolysis  and  40%  rate  of  severe
cysts  at  28  months.
CT  allows  earlier  detection  of  such  lesions,  especially
those  under  the  talar  component,  and  precise  monitoring
of  their  evolution  [12,28].  Periprosthetic  osteolysis  has  also
been  reported  with  other  TAR  models,  both  the  2-component
Agility  implant  [11]  and  3-component  designs  [29—32].
Several  hypotheses  may  be  advanced  to  account  for  the
elevated  rate  and  early  onset  of  evolutive  cysts  in  the
present  AES  TAR  series.
The  tibial  stem  ﬁxation  has  been  incriminated;  cysts,
however,  also  formed  in  the  talus.  The  implant  design  as
such  would  not  seem  to  be  implicated,  as  it  is  similar  to
that  of  the  Buechel  Pappas  TAR,  for  which  Buechel,  the
designer,  reported  92%  10-year  survivorship  [8]  and  Doets
(non-designer)  84%  8-year  survivorship  [29].The  problem  may  lie  in  defective  implant  positioning:
ﬁtting  a  TAR  is  more  operator-dependent  than  ﬁtting  a  hip
or  knee  replacement  [30].  In  the  present  study,  however,
Figure  8  Pale  ﬂakey  material  in  giant  cells  (×20  lens).
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here  were  no  frontal  or  sagittal  positioning  defects  of  more
han  5◦, and  98%  of  implants  were  well  centered  [12].
Bonin  et  al.  [31,34]  suggested  that  some  of  the  cysts
ound  might  have  evolved  from  pre-existing  arthritic  cysts;
he  patients  in  this  study  [34], however,  had  not  had  pre-
perative  CT  scans  screening  for  pre-existing  cysts,  as  was
he  case  in  the  present  series  where  the  cysts  investi-
ated  were  not  found  on  pre-operative  scans  but  appeared
etween  the  ﬁrst  and  second  year  postoperatively,  showing
apid  evolution.  Moreover,  in  agreement  with  Koivu  et  al.
24], the  present  histologic  study  found  metal  particles  and
oreign  bodies,  suggesting  that  Bonin  et  al.’s  hypothesis
31,34]  is  mistaken.
The  polyethylene  of  the  mobile  bearing  may  be  subject  to
he  greatest  stress,  shearing  against  the  tibial  component.
owever,  the  implication  of  polyethylene  in  these  granulo-
atous  formations,  as  found  with  polyethylene  wear  in  hip
eplacement,  is  not  the  only  possibility,  given  the  early  onset
nd  rapid  evolution  of  osteolysis  with  no  macroscopic  signs
f  wear  found  on  the  mobile  part  during  revision  surgery.
The  AES  model  requires  considerable  bone  resection
n  the  tibia  and  talus,  due  to  the  thickness  of  the  tibial
omponent  (5  mm),  the  horizontal  talar  section  and  the  sup-
lementary  anchorage  in  the  talar  neck.  This  cancellous
nchorage,  in  contrast  to  a  subchondral  anchorage  [35,36],
ould  account  for  the  implants  less  satisfactory  primary  sta-
ility,  with  migration  of  wear  debris  [37]. The  talar  cysts,
ndeed,  begin  almost  at  the  level  of  the  talar  component’s
nterior  anchorage  groove  in  the  talar  neck.  There  is  as  yet
o  evidence  regarding  these  factors,  which  remain  hypo-
hetical  and  may  possibly  be  associated.
In  the  present  series,  no  patients  free  of  cysts  at  1  year
ent  on  to  develop  cysts  later.  The  hypothesis  we  adopt  is
herefore  that  the  AES  TAR  has  insufﬁcient  primary  ﬁxation,
eading  to  delamination  of  the  2-layer  coating  and  foreign-
ody  reaction  to  titanium  and  HA  particles,  as  described  by
oivu  et  al.  [24].
The  metallurgy  and  polyethylene  of  the  implants  could
n  principle  be  implicated,  but  all  later  tests  conﬁrmed  that
hey  meet  current  standards.
With  the  ﬁrst  generation  AES  models,  large  amounts  of
etal  particles  were  found,  probably  due  to  the  modular
esign  of  the  tibial  stem;  with  second  generation  models,
rownish  pigments  were  found,  which  may  have  come  from
he  Ti-HA  coating.  The  new  2-layer  Ti-HA  coating  may
ead  to  delamination  by  fretting  during  the  consolidation
f  the  biological  bone  anchorage.  The  titanium  particles
nd  chromium  and  cobalt  ions  probably  come  from  shear
tress  detaching  them  from  the  coating,  leading  to  the
esorptive  inﬂammatory  reaction  seen  in  histology.  Koivu
t  al.  [24]  reported  the  only  histologic  analysis  of  AES
AR  revision  specimens,  with  results  identical  to  those
f  the  present  study:  central  acellular  necrosis  for  the
ystic  formations  and  hystiocytic  macrophagic  granuloma-
ous  inﬂammation  mainly  in  contact  with  polyethylene  and
etallic  foreign  bodies.  In  the  present  study,  metallic  par-
icles,  when  present,  were  not  numerous.  The  bone  tissue
as  in  resorption,  with  rarefaction  of  osteoblasts.  Like  Koivu
t  al.,  we  interpret  this  histologic  aspect  as  a  foreign-body
eaction.  Metallic  particles  were  found  in  all  eight  patients
ith  HA-coated  implants,  whereas  four  of  the  patients  with
i-HA  coating  showed  the  brownish  pigment  discussed  above
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nd  four  others  showed  metallic  particles;  the  brownish  pig-
ent  was  never  associated  with  an  HA  coating,  and  could
erive  from  particles  coming  from  the  Ti-HA,  although  it
as  not  possible  to  demonstrate  this  and,  to  the  best  of
ur  knowledge,  no  studies  have  been  made  of  this  phe-
omenon;  histopathology  alone  is  unable  to  determine  the
xact  nature  of  the  metal  and  certain  other  foreign  particles
38].
To  conﬁrm  the  implication  of  the  2-layer  coating  in  the
enesis  of  these  osteolytic  lesions,  it  would  be  necessary
o  be  able  to  study  the  adherence  of  the  titanium  and
ydroxyapatite  coating  of  AES  TARs  in  comparison  with  the
oatings  of  other  implants  on  the  market.  This  information
as  not  included  in  the  national  health  insurance  coverage
pprovals  delivered  in  2005  for  the  four  implants  authorized
n  France:  AES,  Hintegra,  Salto  and  Star.  Moreover,  the  ver-
ion  of  the  AES  implant  that  was  approved  in  2005  had  a
urely  hydroxyapatite  coating,  and  the  subsequent  abolition
f  modularity  and  the  introduction  of  the  2-layer  coating
ere  not  mentioned  to  the  authorities.  Unfortunately,  the
istributor,  Biomet,  was  unable  to  provide  us  with  unused
mplants  for  testing.
onclusion
AR  osteolysis  is  a  worrying  phenomenon,  and  is  more  fre-
uent  with  the  AES  implant,  jeopardizing  stability.
The  physiopathologic  mechanism  involved  is  poorly
nderstood,  although  wear  debris  from  polyethylene  and
lso  titanium,  chromium,  cobalt  and  perhaps  hydroxyapatite
eem  to  be  at  the  origin  of  this  cell-mediated  inﬂammation.
he  TAR  models  currently  on  the  market  in  Europe  are  made
f  the  same  materials  as  the  AES  and  have  a  2-layer  Ti-HA
oating;  it  is  thus  possible  that  the  issue  arises  even  for  the
mplants  currently  authorized  in  France.
There  are  very  few  independent  series  in  the  literature
hat  could  shed  light  on  survivorship.  Indications  should
herefore  be  made  with  caution  and  the  bone/implant  inter-
ace  should  receive  regular  surveillance.
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